Exchange: ASX Industry: Health Care Equipment & Services
-4.00% $0.0960
America/New_York / 2 mai 2024 @ 01:52
FUNDAMENTALS | |
---|---|
MarketCap: | 3.18 mill |
EPS: | -0.150 |
P/E: | -0.640 |
Earnings Date: | Apr 23, 2024 |
SharesOutstanding: | 33.14 mill |
Avg Daily Volume: | 0.0226 mill |
RATING 2024-05-02 |
---|
C |
Sell |
RATINGS | ||
---|---|---|
Rating CashFlow: | Sell | |
Return On Equity: | Strong Sell | |
Return On Asset: | Strong Sell | |
DE: | Sell | |
P/E: | Sell | |
Price To Book: | Sell |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -0.640 | sector: PE 1.258 |
PE RATIO: COMPANY / INDUSTRY |
---|
-0.01x |
Company: PE -0.640 | industry: PE 54.21 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
$ 0.0900 - 0.102 ( +/- 6.25%) |
ATR Model: 14 days |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 |
Volume Signals | |
---|---|
Price | $0.0960 (-4.00% ) |
Volume | 0.0424 mill |
Avg. Vol. | 0.0226 mill |
% of Avg. Vol | 187.65 % |
Signal 1: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Visioneering Technologies, Inc., a medical device company, engages in the design, manufacture, sale, and distribution of contact lenses in North America, Europe, and the Asia-Pacific. The company's flagship product comprises NaturalVue, a multifocal contact lens for adults with presbyopia and children with myopia. Visioneering Technologies, Inc. was incorporated in 2008 and is headquartered in Alpharetta, Georgia.